doi: 10.3390/ijms23020739 Summary Keywords metabolic reprogramming, glucagon-like peptide-1 receptor agonists, heart failure, cardiovascular system, diabetes Citation Wang X, Qi M, Yang L, Yang L, Wang X, Zhang F, Cui Y, Wang D, Wang Y and Lv W (2025) GLP-1 receptor agonists synergistic effects of metabolic reprogramming and cardioprotection
Bupropion/Naltrexone: This combination targets the brain's reward system to help curb food cravings and support weight management
Novel potential pharmacological applications of dimethyl fumarate-an overview and update
Ann Neurol (1983) 13:67982.10.1002/ana.410130620 99 PinedaMOrmazabalALopez-GallardoENascimentoASolanoAHerreroMDet alCerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion